the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Official Title A Phase 2, Two-Group, Two-Stage, Open-Label Study of Avelumab (MSB0010718C) in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Principal Investigator Fleming, Gini
Brief Summary This research study is evaluating a drug called Avelumab as a possible treatment for recurrent or Metastatic Endometrial Cancer.
Gender Female
Ages 18 Years
Enrollment 70
Accepts Healthy Volunteers No
Lead Sponsor Dana-Farber Cancer InstituteOther
Collaborator PfizerIndustry
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name Gini Fleming, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Metastatic Endometrial Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI